Ye, D., Xu, H., Hu, H., Jiang, S., Zhang, S., Yu, Z., Liu, Z., Niu, H., Cao, Y., Shi, B., Dai, T., Wu, T., Xu, J., Sun, R., Zhang, N., Sun, H. (2026). Phase 1/2 study of an anti-PD-L1/IL-15 variant fusion protein (SIM0237) in BCG-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.764